Literature DB >> 12540522

Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex.

R J Storer1, S Akerman, P J Goadsby.   

Abstract

1. Opioid agonists have been used for many years to treat all forms of headache, including migraine. We sought to characterize opioid receptors involved in craniovascular nociceptive pathways by in vivo microiontophoresis of micro -receptor agonists and antagonists onto neurons in the trigeminocervical complex of the cat. 2. Cats were anaesthetized with alpha-chloralose 60 mg kg(-1), i.p. and 20 mg kg(-1), i.v. supplements after induction and surgical preparation using halothane. Units were identified in the trigeminocervical complex responding to supramaximal electrical stimulation of the superior sagittal sinus, and extracellular recordings of activity made. 3. Seven- or nine-barrelled glass micropipettes incorporating tungsten recording electrodes in their centre barrels were used for microiontophoresis of test substances onto cell bodies. 4. Superior sagittal sinus (SSS)-linked cells whose firing was evoked by microiontophoretic application of L-glutamate (n=8 cells) were reversibly inhibited by microiontophoresis of H(2)N-Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol (DAMGO) (n=12), a selective micro -receptor agonist, in a dose dependent manner, but not by control ejection of sodium or chloride ions from a barrel containing saline. 5. The inhibition by DAMGO of SSS-linked neurons activated with L-glutamate could be antagonized by microiontophoresis of selective micro -receptor antagonists D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH(2) (CTOP) or D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2) (CTAP), or both, in all cells tested (n=4 and 6, respectively). 6. Local iontophoresis of DAMGO during stimulation of the superior sagittal sinus resulted in a reduction in SSS-evoked activity. This effect was substantially reversed 10 min after cessation of iontophoresis. The effect of DAMGO was markedly inhibited by co-iontophoresis of CTAP. 7. Thus, we found that micro -receptors modulate nociceptive input to the trigeminocervical complex. Characterizing the sub-types of opioid receptors that influence trigeminovascular nociceptive transmission is an important component to understanding the pharmacology of this synapse, which is pivotal in primary neurovascular headache.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540522      PMCID: PMC1573664          DOI: 10.1038/sj.bjp.0705034

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

Review 1.  Opioids.

Authors:  S D Silberstein; D C McCrory
Journal:  Cephalalgia       Date:  2000-12       Impact factor: 6.292

2.  The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat.

Authors:  J D Classey; Y E Knight; P J Goadsby
Journal:  Brain Res       Date:  2001-07-13       Impact factor: 3.252

Review 3.  Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs.

Authors:  J G Bovill
Journal:  Eur J Anaesthesiol Suppl       Date:  1997-05

4.  The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study.

Authors:  P J Goadsby; K L Hoskin
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

5.  Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of trigeminothalamic neurons.

Authors:  X M Wang; S S Mokha
Journal:  J Neurophysiol       Date:  1996-09       Impact factor: 2.714

6.  Brainstem activation specific to migraine headache.

Authors:  A Bahra; M S Matharu; C Buchel; R S Frackowiak; P J Goadsby
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

Review 7.  Opioids in headache treatment. Is there a role?

Authors:  D K Ziegler
Journal:  Neurol Clin       Date:  1997-02       Impact factor: 3.806

8.  The global burden of disease study: implications for neurology.

Authors:  M Menken; T L Munsat; J F Toole
Journal:  Arch Neurol       Date:  2000-03

Review 9.  The pharmacology of headache.

Authors:  P J Goadsby
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

10.  Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat.

Authors:  D A Bereiter
Journal:  Neuroscience       Date:  1997-04       Impact factor: 3.590

View more
  6 in total

Review 1.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

2.  Topiramate inhibits trigeminovascular activation: an intravital microscopy study.

Authors:  Simon Akerman; Peter J Goadsby
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 3.  Role of Omics in Migraine Research and Management: A Narrative Review.

Authors:  Pragya Chaturvedi; Rahul Khan; Prachi Sahu; Abhilash Ludhiadch; Gagandeep Singh; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.682

4.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

Review 5.  Convergence of cervical and trigeminal sensory afferents.

Authors:  Elcio J Piovesan; Pedro A Kowacs; Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2003-10

6.  Nociception-specific blink reflex: pharmacology in healthy volunteers.

Authors:  J C A Marin; A R Gantenbein; K Paemeleire; H Kaube; P J Goadsby
Journal:  J Headache Pain       Date:  2015-10-08       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.